Portal de Periódicos da CAPES

Risk of Atypical Femoral Fracture during and after Bisphosphonate Use

2014; Massachusetts Medical Society; Volume: 371; Issue: 10 Linguagem: Inglês

10.1056/nejmc1403799

1533-4406

Jörg Schilcher, Veronika Koeppen, Per Aspenberg, Karl Michaëlsson,

Bone fractures and treatments

This letter indicates that there is long-lasting skeletal accumulation of bisphosphonate, and ongoing use appears to be the dominant risk factor for rare fractures.